Biosimilars: British Columbia extends transition programBy Aurélia Morvan | October 03 2019 11:14AM
Rising drug costs are plaguing public and private health insurance plans alike. In response to this trend, British Columbia has extended its program which transitions patients to biosimilar drugs.
This article is reserved to PRO Level subscribers
Read the whole article….
$9.95 / month
The most popular in Health
Related to the same topic …